Chronic renal failure. End stage kidney disease:on dialysis
Conditions
Interventions
Intervention 1: CONTROL: temperature of hemodialysis fluid (dialysate) is regulated on 37 ° C . Type of filter, coefficient of ultra-filtration, blood flow rate and type of apparatus are constant duri
CONTROL: temperature of hemodialysis fluid (dialysate) is regulated on 37 ° C . Type of filter, coefficient of ultra-filtration, blood flow rate and type of apparatus are constant during the study.
intervention: temperature of hemodialysis fluid is regulated on (35.5 ° C) and type of filter, coefficient of ultra-filtration, blood flow rate are not changed.
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: consent for participation in the study; Age older than 18 years and maximum 65 years; suffering from vision, hearing loss (deafness and dumbness); not suffering from clear mental disorders and severe emotional mood disorders, which prevent effective communication; Patients with chronic renal failure (patients who 3 months have passed since their dialysis); patients who have Arteriovenous fistulas for hemodialysis; Patients receiving dialysis treatment three times a week and each session for 4 hours; patients who over the past 2 months, have a history of itching during hemodialysis; not suffering from endocrine disorders (such as hypothyroidism, hyperparathyroidism; not suffering from febrile illnesses (pneumonia, colds); No history of pruritic skin diseases; No use of medications or foods, causing itching; Lack of pregnancy and liver problems; Patients with a KT / V =1; Patients with hemoglobin of 10-11 mg / dl Exclusion criteria: Patients who develop acute complications during hemodialysis (Disequilibrium syndrome - embolism - dysrhythmia – cardiac, respiratory arrest - Coma -); Patients who suffer from skin disorders that lead to the itch (Scabies - psoriasis); patients who discontinued they dialysis for any reason; Patients who are referred for kidney transplants (Patients who get kidney transplantation during the study); Change in the frequency of hemodialysis, the patient's death, patients who cannot tolerate cold dialysis; woman patients who become pregnant, hemodialysis with acetate, the incidence of fever, the patient's unwillingness to continue to participate in the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pruritus. Timepoint: Before, during and after intervention. Method of measurement: Vas-scale assessment and questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElaheh Jaghouri
Sabzevar University of Medical Sciences
Outcome results
None listed